1887
Preview this article:
Zoom in
Zoomout

Penicillin/ampicillin efficacy among children with severe pneumonia due to penicillin-resistant pneumococcus (MIC=4 μg ml), Page 1 of 1

| /docserver/preview/fulltext/jmm/58/10/1390-1.gif

There is no abstract available for this article.
Use the preview function to the left.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.007765-0
2009-10-01
2020-08-10
Loading full text...

Full text loading...

/deliver/fulltext/jmm/58/10/1390.html?itemId=/content/journal/jmm/10.1099/jmm.0.007765-0&mimeType=html&fmt=ahah

References

  1. Aguado-García J. M., Martín-Herrero J. E., Lumbreras-Bermejo C. 2004; Bacterial resistance and pharmacodynamics as the basis for prescribing antibiotics in respiratory infections. Enferm Infecc Microbiol Clin 22:230–237 [CrossRef]
    [Google Scholar]
  2. Ayieko P., English M. 2007; Case management of childhood pneumonia in developing countries. Pediatr Infect Dis J 26:432–440 [CrossRef]
    [Google Scholar]
  3. Cardoso M. R. A., Nascimento-Carvalho C. M., Ferrero F., Berezin E. N., Ruvinsky R., Camargos P. A. M., Sant'anna C. C., Brandileone M. C. C., March M.-F. P. other authors 2008; Penicillin resistant pneumococcus and risk of treatment failure in pneumonia. Arch Dis Child 93:221–225 [CrossRef]
    [Google Scholar]
  4. CLSI 2007 Performance Standards for Antimicrobial Susceptibility Testing; Fifteenth Informational Supplement . Document M100-S15 Wayne, PA: Clinical and Laboratory Standards Institute;
    [Google Scholar]
  5. CLSI 2008 Performance Standards for Antimicrobial Susceptibility Testing; Sixteenth Informational Supplement . Document M100-S15 Wayne, PA: Clinical and Laboratory Standards Institute;
    [Google Scholar]
  6. Dagan R. 2003; Achieving bacterial eradication using pharmacokinetic/pharmacodynamic principles. Int J Infect Dis 7 (Suppl. 1):S21–S26 [CrossRef]
    [Google Scholar]
  7. Facklam R. R., Washington J. A. 1991; Streptococcus and related catalase-negative Gram positive cocci. In Manual of Clinical Microbiology , 5th edn. pp 238–257 Edited by Balows A., Hausler W. J. Jr, Hermann K. L., Isenberg H. D., Shadomy H. J. Washington, DC: American Society for Microbiology;
    [Google Scholar]
  8. Heffelfinger J. D., Dowell S. F., Jorgensen J. H., Klugman K. P., Mabry L. R., Musher D. M., Plouffe J. F., Rakowsky A., Schucht A. other authors 2000; Management of community-acquired pneumonia in the era of pneumococcal resistance. Arch Intern Med 160:1399–1408 [CrossRef]
    [Google Scholar]
  9. Jacobs M. R. 2003; How can we predict bacterial eradication?. Int J Infect Dis 7 (Suppl. 1):S13–S20 [CrossRef]
    [Google Scholar]
  10. Rothermel C. D. 2004; Penicillin and macrolide resistance in pneumococcal pneumonia: does in vitro resistance affect clinical outcomes?. Clin Infect Dis 38 (Suppl. 4):S346–S349
    [Google Scholar]
  11. Sinaniotis C. A., Sinaniotis A. C. 2005; Community-acquired pneumonia in children. Curr Opin Pulm Med 11:218–225 [CrossRef]
    [Google Scholar]
  12. WHO 1990 ARI in Children: Case Management in Small Hospitals in Developing Countries. A Manual for Doctors and Other Senior Health Workers . Programme for the Control of ARI Geneva: World Health Organization;
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.007765-0
Loading
/content/journal/jmm/10.1099/jmm.0.007765-0
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error